• This record comes from PubMed

Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation

. 2019 Feb ; 94 (2) : E50-E53. [epub] 20181213

Language English Country United States Media print-electronic

Document type Clinical Trial, Letter, Research Support, Non-U.S. Gov't

Grant support
PROGRES Q28/LF1 Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations - International
PROGRES Q26/LF1 Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations - International
UNCE/MED/016 Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations - International
AZV 17-28980A Ministry of Education, Youth and Sports Institutional Support for Long-term Development of Research Organizations - International
Charles University Center of Excellence - International
Ministry of Health of the Czech Republic - International

References provided by Crossref.org

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...